Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide chemotherapy.
Damasiewicz
M J
MJ
Chionh
F J M
FJ
Hayes
T
T
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D004890:Erythema / Q000139:chemically induced; D005260:Female; D005528:Foot; D006225:Hand; D006801:Humans; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D004317:Doxorubicin; D003520:Cyclophosphamide